Investors Buzz: Halozyme Therapeutics, Inc. (NASDAQ:HALO), Zynga Inc (NASDAQ:ZNGA), Baidu.com, Inc. (ADR) (NASDAQ:BIDU)

Dallas, TX -- (SBWIRE) -- 03/22/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Halozyme Therapeutics, Inc. (NASDAQ:HALO) shares climbed 17.65% to $6.20 after Baxter International Inc. (NYSE:BAX) and Halozyme today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (EMA CHMP) has granted a Positive Opinion to Baxter for the use of HyQvia (solution for subcutaneous use) as replacement therapy for adult patients with primary and secondary immunodeficiencies. The product is a combination of human normal immunoglobulin (IGSC, 10%) and recombinant human hyaluronidase, which facilitates the dispersion and absorption of the IGSC.

How Should Investors Trade HALO After The Recent Price movement? Find out Here

Zynga Inc (NASDAQ:ZNGA) shares jumped 2.36% to $3.43 after Credit Agricole started coverage on shares of Zynga in a research note issued today. The firm set an “underperform” rating on the stock.

Additionally, the company recently said it is cutting about 1% of its staff, amounting to several dozen employees, as the social-games firm shutters its Baltimore office and consolidates others in a cost-cutting move. The company said in a statement it is shutting its Baltimore studio, which employed fewer than 50 people, and sending some of those employees elsewhere.

Is ZNGA a Strong Buying Opportunity After The Recent Slump? Find out Here

Baidu.com, Inc. (ADR) (NASDAQ:BIDU) shares increased 0.02% to $85.94. The company, on Feb. 4, announced that for the first quarter of 2013, it expects total revenues in an amount ranging from RMB5.890 billion ($945.4 million) to RMB6.080 billion ($975.9 million). Analysts on an average are expecting the Company to report revenues $963.7 million for the first quarter of 2013.

Additionally, CLSA last month has downgraded Internet search engine provider BIDU to Underperform from a Buy citing competition and other reasons. Earlier Goldman Sachs had reduced the target price on its shares to $89 from $135, and put out a bearish note on the company.

Is BIDU a Buy After The Latest Price Action? Find Out Here

About Marketbuzzreport.com
Marketbuzzreport.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. Marketbuzzreport.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.marketbuzzreport.com

Disclaimer
The assembled information disseminated by Marketbuzzreport.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Marketbuzzreport.com does expect that investors will buy and sell securities based on information assembled and presented in Marketbuzzreport.com. PLEASE always do your own due diligence, and consult your financial advisor.